Mutations in the exonuclease domain of the polymerase epsilon (POLE) gene are associated with an ultra-mutated genetic phenotype, increased neoantigen load, increased tumour infiltrating lymphocytes, and potential responsiveness to immune therapy [1–5]. The gene discussed is POLE; the disease is neoplasm.